153 related articles for article (PubMed ID: 30695331)
1. [Biologics-Induced Kidney Injury -with Special Attention to Anti-Rheumatic Drugs -].
Kimura H
Rinsho Byori; 2016 Jun; 64(6):718-722. PubMed ID: 30695331
[TBL] [Abstract][Full Text] [Related]
2. Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort.
Piga M; Chessa E; Ibba V; Mura V; Floris A; Cauli A; Mathieu A
Autoimmun Rev; 2014 Aug; 13(8):873-9. PubMed ID: 24840285
[TBL] [Abstract][Full Text] [Related]
3. Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.
Chessa E; Piga M; Floris A; Congia M; Cangemi I; Mathieu A; Cauli A
BioDrugs; 2021 Mar; 35(2):175-186. PubMed ID: 33595833
[TBL] [Abstract][Full Text] [Related]
4. Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis.
Nakano M; Ueno M; Nishi S; Shimada H; Hasegawa H; Watanabe T; Kuroda T; Sato T; Maruyama Y; Arakawa M
Clin Nephrol; 1998 Sep; 50(3):154-60. PubMed ID: 9776418
[TBL] [Abstract][Full Text] [Related]
5. [Kidney involvement in rheumatoid arthritis].
Icardi A; Araghi P; Ciabattoni M; Romano U; Lazzarini P; Bianchi G
Reumatismo; 2003; 55(2):76-85. PubMed ID: 12874640
[TBL] [Abstract][Full Text] [Related]
6. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.
Choy EH; Smith C; Doré CJ; Scott DL
Rheumatology (Oxford); 2005 Nov; 44(11):1414-21. PubMed ID: 16030080
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological study of nephropathy in patients with rheumatoid arthritis].
Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Koyama K; Oikawa T; Fujinimi T; Matsumoto Y
Ryumachi; 1991 Feb; 31(1):14-21. PubMed ID: 1677490
[TBL] [Abstract][Full Text] [Related]
9. [Anti-rheumatic therapy in patients with rheumatoid arthritis undergoing hemodialysis].
Akiyama Y
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(6):485-92. PubMed ID: 22214809
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of chronic kidney disease and administration of RA-related drugs in patients with RA: The NinJa 2012 study in Japan.
Saisho K; Yoshikawa N; Sugata K; Hamada H; Tohma S
Mod Rheumatol; 2016; 26(3):331-5. PubMed ID: 26374955
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biological Activities of Chemical Drugs for the Treatment of Rheumatoid Arthritis.
Zhou S; Zou H; Chen G; Huang G
Top Curr Chem (Cham); 2019 Sep; 377(5):28. PubMed ID: 31563994
[TBL] [Abstract][Full Text] [Related]
12. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
Li N; Betts KA; Messali AJ; Skup M; Garg V
Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
[TBL] [Abstract][Full Text] [Related]
13. Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies.
Chen J; Chi S; Li F; Yang J; Cho WC; Liu X
Expert Opin Biol Ther; 2017 Mar; 17(3):265-283. PubMed ID: 28117616
[TBL] [Abstract][Full Text] [Related]
14. Renal involvement in rheumatoid arthritis: analysis of renal biopsy specimens from 100 patients.
Makino H; Yoshinaga Y; Yamasaki Y; Morita Y; Hashimoto H; Yamamura M
Mod Rheumatol; 2002 Jun; 12(2):148-54. PubMed ID: 24383903
[TBL] [Abstract][Full Text] [Related]
15. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
16. Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial.
Karstila KL; Rantalaiho VM; Mustonen JT; Möttönen TT; Hannonen PJ; Leirisalo-Repo M; Kaipiainen-Seppänen OA; Karjalainen AH; Korpela MM;
Clin Exp Rheumatol; 2010; 28(1):73-8. PubMed ID: 20346242
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumour necrosis factor-alpha inhibitors on renal function in patients with rheumatoid arthritis from the KOBIO registry from 2012 to 2016.
Kim SK; Choe JY; Kwak SG; Bae J; Park SH; Lee H
Clin Exp Rheumatol; 2018; 36(6):1022-1030. PubMed ID: 29652655
[TBL] [Abstract][Full Text] [Related]
18. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
19. Are biologics more effective than classical disease-modifying antirheumatic drugs?
Nurmohamed MT; Dijkmans BA
Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 65 Renal Biopsies From Patients With Rheumatoid Arthritis (1976-2015): Change in Treatment Strategies Decreased Frequency and Modified Histopathological Findings.
Vinicki JP; Pellet SC; De Rosa G; Dubinsky D; Laborde HA; Marini A; Nasswetter G
J Clin Rheumatol; 2015 Oct; 21(7):335-40. PubMed ID: 26398458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
